These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16171799)

  • 1. Ciglitazone inhibits the antigen-induced leukotrienes production independently of PPARgamma in RBL-2H3 mast cells.
    Okuyama K; Yamashita M; Kitabatake Y; Kawamura S; Takayanagi M; Ohno I
    Eur J Pharmacol; 2005 Oct; 521(1-3):21-8. PubMed ID: 16171799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells.
    Yamashita M
    Eur J Pharmacol; 2007 Feb; 556(1-3):172-80. PubMed ID: 17113579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells.
    Yamashita M; Kushihara M; Hirasawa N; Takasaki W; Takahagi H; Takayanagi M; Ohuchi K
    Br J Pharmacol; 2000 Jan; 129(2):367-73. PubMed ID: 10694244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
    Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
    J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-MMP-2 activation by the PPARgamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK.
    Kim KH; Cho YS; Park JM; Yoon SO; Kim KW; Chung AS
    FEBS Lett; 2007 Jul; 581(17):3303-10. PubMed ID: 17597617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.
    Kwon CH; Yoon CS; Kim YK
    Toxicology; 2008 Feb; 244(1):13-24. PubMed ID: 18082925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel PPAR response element in the murine iNOS promoter.
    Crosby MB; Svenson J; Gilkeson GS; Nowling TK
    Mol Immunol; 2005 Jul; 42(11):1303-10. PubMed ID: 15950726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense.
    Zhang YF; Yang X; Zhang YJ; Sun YL; Zou XL; Kong QY; Dong XQ; Ye XQ; Yu XQ
    Am J Nephrol; 2006; 26(6):602-11. PubMed ID: 17183189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role for peroxisome proliferator-activated receptor gamma in regulating luteal lifespan in the rat.
    Tinfo N; Komar C
    Reproduction; 2007 Jan; 133(1):187-96. PubMed ID: 17244745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists.
    Mellor EA; Austen KF; Boyce JA
    J Exp Med; 2002 Mar; 195(5):583-92. PubMed ID: 11877481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats.
    Lin TH; Yang RS; Tang CH; Lin CP; Fu WM
    Bone; 2007 Oct; 41(4):562-74. PubMed ID: 17669705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma (PPARgamma) regulates trefoil factor family 2 (TFF2) expression in gastric epithelial cells.
    Shimada T; Fujii Y; Koike T; Tabei K; Namatame T; Yamagata M; Tajima A; Yoneda M; Terano A; Hiraishi H
    Int J Biochem Cell Biol; 2007; 39(3):626-37. PubMed ID: 17118693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone inhibits HMC-1 cell migration and adhesion through a peroxisome proliferator-activated receptor gamma-dependent mechanism.
    Zhang G; Yang J; Li P; Cao J; Nie H
    Iran J Allergy Asthma Immunol; 2014 Feb; 13(1):11-8. PubMed ID: 24338223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
    Chana RS; Lewington AJ; Brunskill NJ
    Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
    Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells.
    Hampel JK; Brownrigg LM; Vignarajah D; Croft KD; Dharmarajan AM; Bentel JM; Puddey IB; Yeap BB
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):283-93. PubMed ID: 16647253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.